COMMUNIQUÉS West-GlobeNewswire

Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product Development
13/08/2025
TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical Textiles Innovation Lab, [...]
Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity
13/08/2025
This is the first ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease The Phase 1/2 study (up to 141 participants) will evaluate the [...]
Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye
13/08/2025
Pratteln, Switzerland , 13 August , 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion [...]
Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
13/08/2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat [...]
Maximus Ranks No. 27 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 7260.85%, This Marks Maximus' 1st Time on the List Los Angeles, CA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
12/08/2025
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026 Announced positive data from Phase 1b/2a RESOLVE supporting the potential of [...]
vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual property portfolio [...]
Sienna Reports Second Quarter 2025 Financial Results and Publishes 2025 Impact Report
12/08/2025
MARKHAM, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2025. Highlights [...]
First Lady Anna Stein, NCDHHS and Morse Clinics Celebrate First Mobile Opioid Treatment Program Unit in North Carolina
12/08/2025
Raleigh, NC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Credentialed media are invited to attend the unveiling of the first Mobile Opioid Treatment Program (OTP) unit in North Carolina. Mobile OTPs reduce barriers to [...]
PetMed Express, Inc. Announces Management Changes
12/08/2025
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and [...]
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
12/08/2025
- Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial [...]
ImmuCell Announces Bank Debt Refinancing
12/08/2025
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Zevra Reports Second Quarter 2025 Financial Results and Corporate Update
12/08/2025
Q2 2025 net revenue of $25.9 million , driven by product net revenue of $21.8 million Completed sale of PRV for $150.0 million , bolstering the balance sheet as the Company executes on its commercial launches and [...]
LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth
12/08/2025
LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc . (OTC: LGMK) (the Company), a provider of personal safety, personal emergency response systems (PERS), health communications devices, and technology for [...]
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
– Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q’25 – – Type 2a meeting with the FDA anticipated in 4Q’25– – Cash runway [...]
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
12/08/2025
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced [...]
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 [...]
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
12/08/2025
Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial design elements. [...]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
12/08/2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of [...]

Pages